MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 1061-1070 Newer>
The Motley Fool
March 16, 2004
David Nierengarten
Sanofi Slimming Pill Sanofi's new drug, Acomplia, shows promise for weight loss and smoking cessation. mark for My Articles 214 similar articles
CIO
March 15, 2004
Alison Bass
Health-Care I.T As more health-care providers move toward electronic medical records that they can easily share via the Internet, the potential for abuse grows. mark for My Articles 167 similar articles
BusinessWeek
March 22, 2004
Arlene Weintraub
Amgen Opens The Secret Curtain The biotech leader will host analysts and investors to drum up excitement for its pipeline -- and its stock. Will it work? mark for My Articles 256 similar articles
BusinessWeek
March 22, 2004
Robert Barker
St. Jude: An Insider Sign To Investors? St. Jude, the patron saint of lost causes, rarely has needed to look out for his namesake, St. Jude Medical (STJ ). Since its birth in 1976, this maker of artificial heart valves, defibrillators, catheters, and sundry other cardiac devices has led a blessed life. It's in excellent health today. So why are insiders dumping the stock? mark for My Articles 101 similar articles
Science News
March 13, 2004
Edna Francisco
Formula for Failure A bacterium that has been known to cause rare, yet fatal infections in infants appears to be more widespread than scientists have realized. mark for My Articles 37 similar articles
BusinessWeek
March 22, 2004
Gene G. Marcial
Look Who May Be Courting Bioenvision Genzyme may be interested in Bioenvision as well. Why? In 2001, Bioenvision licensed to ILEX the right to co-develop and market in the U.S. and Canada its Clorfarabine, a drug for leukemia. Bioenvision still holds the rights outside North America. The company will soon file for Food & Drug Administration approval of Clorfarabine, which has a $1 billion market potential. mark for My Articles 65 similar articles
The Motley Fool
March 11, 2004
Bill Mann
Pennsylvania Sues Drug Makers Anyone who thinks that the new prescription drug benefit plan (the Medicare Modernization Act) signed by President Bush will have anything resembling predictable expenses needs to pay attention to what's going on in Pennsylvania. The commonwealth filed suit yesterday against 13 large drug companies, accusing them of price manipulation. mark for My Articles 469 similar articles
Technology Research News
March 10, 2004
Atomic microscope spots viruses Researchers from BioForce Nanosciences Inc., Iowa State University and Des Moines University have combined an atomic force microscope with a method of capturing virus particles to produce a tool that rapidly detects viruses. mark for My Articles 187 similar articles
The Motley Fool
March 9, 2004
Rich Smith
Interpore Gets Transplanted Will its acquisition by medical equipment maker Biomet pay off for Interpore's shareholders? mark for My Articles 20 similar articles
The Motley Fool
March 9, 2004
David Nierengarten
Sepracor's No Sleeper FDA approval for its sleeping medication sends Sepracor's stock up 70%. mark for My Articles 103 similar articles
<Older 1061-1070 Newer>    Return to current articles.